Verbio (VBK) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 May, 2026Executive summary
Strong Q3 and nine-month performance driven by robust GHG quota demand, improved market conditions, and record biomethane and bioethanol production.
Ramp-up of the Nevada plant and improved uptime at South Bend Ethanol contributed to higher production and earnings.
Regulatory support, including RED III in Germany and increased GHG quotas, strengthened sector outlook.
Positive free cash flow and reduced net financial debt, with equity ratio improving to 59.3%.
Net result for the period reached €22.3 million, reversing a prior year loss.
Financial highlights
Revenue for the first nine months rose 17% year-over-year to €1,340.7 million, driven by higher production, sales volumes, and GHG quota demand.
EBITDA for the nine months surged to €164.0 million from €105.7 million year-over-year; Q3 EBITDA reached €60.2 million.
Operating cash flow for nine months was €96.4 million, with free cash flow at €33.0 million.
Net debt reduced to €22.4 million from €126.8 million, with equity ratio stable at 59.3%.
EBIT for the nine months was €58.3 million, compared to a loss of €24.2 million year-over-year.
Outlook and guidance
EBITDA guidance for FY 2025/26 raised to the upper end of €100–140 million, reflecting strong business performance and regulatory tailwinds.
Net financial debt expected to be less than €140 million by year-end, with net debt/EBITDA targeted below 1x.
Production capacity utilization expected to increase year-over-year across all segments.
Forecast range remains wide due to ongoing geopolitical uncertainties.
Market expects continued strong demand for biofuels due to regulatory and geopolitical factors.
Latest events from Verbio
- Profitability rebounds as regulatory clarity, innovation, and global expansion drive growth.VBK
German Select VII Conference15 Apr 2026 - Revenue up 19% and EBITDA tripled, driven by higher production and GHG quota demand.VBK
Q2 25/2612 Apr 2026 - Record biofuel output and growth investments set stage for higher EBITDA in FY 2024/25.VBK
Q4 23/2420 Jan 2026 - EBITDA and revenue fell, but guidance and regulatory support remain positive for FY 2024/25.VBK
Q1 24/2514 Jan 2026 - EBITDA and revenue fell, but Q2 rebounded and guidance was cut amid market and technical headwinds.VBK
Q2 24/2516 Dec 2025 - EBITDA and revenue fell, but production hit records; guidance and CapEx were cut.VBK
Q3 24/2518 Nov 2025 - Revenue up 22%, EBITDA surged, and outlook for FY 2025/2026 remains strong.VBK
Q1 25/2612 Nov 2025 - EBITDA fell on weaker margins and impairment, but outlook is positive with rising global demand.VBK
Q4 24/2525 Sep 2025